Stereochemistry, and complete 1H and 13C NMR signal assignment of C-20-oxime derivatives of posterone 2,3-acetonide in solution state by Bogdán, Dóra et al.
4Ediburgh Cancer Research UK Centre MBC Institute of
Genetics and Molecular Medicine, University of
Edinburgh, Crewe Road South, Edinburgh EH4,
2XR, UK
5Avenida de la Ilustración 114, Parque Tecnológico de
Ciencias de la Salud, Centro Pfizer‐Universidad de
Granada‐Junta de Andalucía de Genómica e Investigación
Oncológica (GENYO), 18016 Granada, Spain
Correspondence
Juan José Díaz‐Mochón, Departamento de Química
Farmacéutica y Orgánica, Facultad de Farmacia, Campus
de Cartuja, Universidad de Granada, Granada, Spain.
Email: juandiaz@ugr.es
María José Pineda de las Infantas Villatoro, Departamento
de Química Farmacéutica y Orgánica, Facultad de
Farmacia, Campus de Cartuja, Universidad de Granada,
Granada, Spain.
Email: mjpineda@ugr.es
REFERENCES
[1] Z. O'Brien, M. Moghaddam, Expert Opin. Drug Metab. Toxicol.
2013, 9, 1597.
[2] L. Meijer, E. Raymond, Acc. Chem. Res. 2003, 36, 417.
[3] P. G. Baraldi, A. Unciti‐Broceta, M. J. Pineda de las Infantas, J. J.
Díaz‐Mochón, A. Espinosa, R. Romagnoli, Tetrahedron 2002, 58,
7607.
[4] M. J. Pineda de las Infantas, J. D. Unciti‐Broceta, R. Contreras, J.
A. García, M. A. Gallo, A. Unciti‐Broceta, J. J. Díaz‐Mochón, Sci.
Rep. 2015, 5, 9139.
[5] M. J. Pineda de las Infantas, S. Torres‐Rusillo, J. D. Unciti‐
Broceta, P. Fernández‐Rubio, M. A. Luque‐González, M. A.
Gallo, A. Unciti‐Broceta, I. J. Molina, J. J. Díaz‐Mochón, Org.
Biomol. Chem. 2015, 13, 5234.
[6] L. Harmse, R. van Zyl, N. Gray, P. Schultz, S. Leclerc, L. Meijer,
C. Doerig, I. Havlik, Biochem. Pharmacol. 2001, 62, 341.
[7] D. M. Doddrell, D. T. Pegg, M. R. Bendall, J. Magn. Reson. 1969,
1982.
[8] R. Boyer, R. Johnson, K. Krishnamurthy, J. Magn .Reson. 2003,
2, 165.
DOI: 10.1002/mrc.4750
Stereochemistry and complete 1H and 13C NMR signal
assignment of C‐20‐oxime derivatives of posterone 2,3‐
acetonide in solution state
1 | INTRODUCTION
Less polar derivatives of ecdysteroids, and particularly
their acetonides and other dioxolane analogs, were
previously shown by our group to exert a strong chemo‐
sensitizing activity on cancer cells to common chemo-
therapeutics, including doxorubicin, vincristine, and
paclitaxel.[1,2] While this sensitizing activity could also
be observed on drug‐susceptible cancer cells, a high
selectivity was found towards multidrug resistant (MDR)
cancer cell lines transfected to overexpress the ABCB1
multidrug transporter.[2,3] Interestingly, the chemo‐
sensitizing activity was independent of a functional efflux
inhibition: even though some of the tested compounds
showed a mild to moderate ABCB1 inhibitory activity;
structure–activity relationships for efflux inhibition
were significantly different to those describing chemo‐
sensitizing activity.[1] In particular, several poststerone
derivatives, containing a substituted dioxolane (e.g.,
acetonide) moiety connected to their A‐ring, were found
to be free from the efflux pump inhibitory activity, while
acting as strong chemo‐sensitizers in combination with
doxorubicin.[3] In addition to this, ecdysteroid 6‐oximes
and oxime ethers demonstrated markedly increased
ABCB1 inhibitory activity, while acting as similarly potent
chemo‐sensitizers as their corresponding 6‐oxo analogs.[4]
Self‐assembling nanoparticles provide a promising
novel approach against cancer.[5] These can be prepared
by functionalizing a potential antitumor agent with a
long lipophilic side‐chain through functional group(s)
hydrolysable in a biological environment (e.g., ester),
which will make them working as prodrugs once
released. The role of the side‐chain in such a conjugate
is to induce the self‐assembly to nanoparticles in aqueous
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environment due to secondary interactions.[6–8] In our pre-
vious work, we applied two different types of linkers: one
only with CH2 units and another with S―S disulfide
bridge in the middle of this unit. This last one was found
rather advantageous to release the drug molecules from a
prodrug form mainly in the inner environment of cancer
cells.[9] As part of a research program aiming to prepare
and study such compounds from certain ecdysteroids, we
turned our attention towards the 20‐oxime of poststerone
2,3‐acetonide, a potentially strong antitumor ecdysteroid
derivative, and its conjugates with long lipophilic side‐
chains. Due to the abundancy of overlapping signals in
the aliphatic region, a complete NMR signal assignment
of such compounds bears a significant challenge. Accord-
ingly, to the best of our knowledge, no previous studies
are available on the full NMR characterization of such
self‐assembling drug conjugates.
Most recently, Savchenko and coworkers reported the
regioselective preparation of this ecdysteroid oxime, along
with its X‐ray single crystal investigation and NMR data lim-
ited to the nonoverlapping 1H signals.[10] In the present
study, our aim was to perform an in‐depth, high‐resolution
NMR investigation on this compound, two of its oxime ether
derivatives, and two of its conjugates with long lipophilic
side‐chains, potentially able to self‐assemble. Publication of
the antitumor activity and nanoparticle forming properties
of the latter two compounds is just accepted elsewhere.[11]
2 | EXPERIMENTAL
2.1 | Substances
Chemical structures and synthesis of compounds 2–7 are
shown in Figure 1.
2.1.1 | Synthesis and purification of com-
pound 2
Poststerone 2,3‐acetonide (1) was prepared according to
previously published procedures.[3] Oximation of deriva-
tive 1 was performed at RT, by dissolving 42.2 mg
(0.104 mmol) of the substrate in a round‐bottom flask in
freshly distilled pyridine. A 10.9 mg (0.157 mmol;
1.5 equivalents) of hydroxylamine hydrochloride was
added, and the solution was left stirring for 25 min. Fol-
lowing this, the reaction mixture was cooled to 0 °C,
and potassium hydroxide (8.8 mg; 0,157 mmol), dissolved
in 1 ml of anhydrous ethanol, was added under stirring.
The obtained mixture was evaporated under reduced
pressure using a rotary evaporator, and water (30 ml)
was added to the crude solid followed by extraction with
ethyl acetate (4 × 30 ml). The combined organic fractions
were dried over Na2SO4 and filtered, and the solution was
evaporated under reduced pressure to obtain 40.17 mg of
crude mixture. RP‐HPLC purification was performed
using an Agilent Eclipse XDB‐C8 250 × 9.4 mm 5 μm
semipreparative column (Agilent Technologies Inc.,
USA) by using isocratic elution with 35% acetonitrile
and 65% water at a flow rate of 3 ml/min to obtain
poststerone 2,3‐acetonide 20‐oxime (2) in a yield of
69.7% (30.69 mg) and a RP‐HPLC purity of 99.1%.
2.1.2 | Synthesis and purification of com-
pound mixture 3
Three hundred milligrams (0.745 mmol) of ecdysteroid
substrate 1 was dissolved in 6 ml of freshly distilled pyri-
dine in a round‐bottom flask. A 186.7 mg (2.235 mmol,
three equivalents) of methoxyamine hydrochloride was
FIGURE 1 Chemical structures and preparation of ecdysteroid derivatives 2–3 and 6–7. Reagents and conditions: (a; 1) NH2OH·HCl
(1.5 eq.), Py, RT, 25 min (2) KOH in anhydrous EtOH; (b; 1) NH2OMe·HCl (3 eq.), Py, 70 °C, 5.5 hr (2) KOH/EtOH; (c) 4 or 5 (1.5 eq.), DCM,
DMAP (2 eq.), EDC·HCl (2.5 eq.), Ar
860 LETTER ‐ SPECTRAL ASSIGNMENTS
added, and the mixture was left stirring at 70 °C for
5.5 hr. Following this, the reaction mixture was cooled
to 0 °C, and neutralization was performed with potassium
hydroxide (125.4 mg; 2.235 mmol) dissolved in 5 ml of
anhydrous ethanol. The obtained mixture was evaporated
using a rotary evaporator, and 40 ml of water was added,
followed by extraction with ethyl acetate (4 × 40 ml). The
combined organic fractions were dried over Na2SO4 and
filtered, and the solution was evaporated under reduced
pressure to obtain a crude mixture of isomeric O‐
methylated 20‐oximes and 6,20‐dioximes. Flash chro-
matographic purification was performed using a 30 g
RP‐C18 column with gradient elution of acetonitrile
increasing from 40% to 55% in 45 min (flow rate:
35 ml/min; UV detection: 254 nm). The fractions collected
between 17 and 30 min were combined and evaporated
under reduced pressure to obtain a mixture of (E/Z)‐
isomeric 20‐O‐methyl oxime ethers (3) in a combined yield
of 12% (38.58 mg, combined RP‐HPLC purity: 98.3%).
2.1.3 | Synthesis and purification of
ecdysteroid conjugates 6 and 7
Functionalization of self‐assembly inducer squalene and
the preparation of its coupled derivatives 4 and 5 attached
to a linker moiety were prepared following previously pub-
lished procedures.[12] A 34.2 mg (0.0819 mmol) of
ecdysteroid substrate 2 was dissolved in 6 ml of anhydrous
dichloromethane in a two‐neck round‐bottom flask. The
1.5 equivalents of the disulfide bridge containing com-
pound 4 (74.6 mg, 0.1229 mmol) or Substrate 5 (70.2 mg,
0.1229 mmol) were added dropwise under stirring. Follow-
ing this, 13.1 mg (0.1638 mmol, two equivalents) of
dimethylaminopyridine and 39.3 mg (0.205 mmol,
2.5 equivalents) of (3‐dimethylaminopropyl)‐N′‐
ethylcarbodiimide hydrochloride were added, and the mix-
ture was left stirring at room temperature under argon
atmosphere for 2 hr. After completion, the mixture was
neutralized with 10% aqueous NaHCO3, brine (30 ml)
was added, and extraction was performed with dichloro-
methane (4 × 30 ml). Following this, the combined
organic fractions were dried over NasSO4 and filtered,
and the solution was evaporated under reduced pressure.
Flash chromatographic purification was carried out on 4‐
g silica columns using isocratic grade eluents of 65% n‐
hexane and 35% ethyl acetate in case of product 6 and
75% n‐hexane and 25% ethyl acetate in case of product 7
to obtain the compounds as colorless oils.
2.2 | Further experimental details
Solvents and reagents were purchased from Sigma
(Sigma‐Aldrich Co., USA). All HPLC analysis, including
purification, were carried out on a Jasco HPLC instru-
ment (Jasco Analytical Instruments, Japan) coupled with
an MD‐2010 Plus PDA detector, applied in a detection
range of 210–400 nm. Flash chromatographic purification
was performed on a Combiflash Rf+ instrument
(TELEDYNE Isco, USA) equipped with diode array detec-
tion ‐ evaporative light scattering detection (DAD‐ELSD)
using commercially available prefilled RediSep columns
(TELEDYNE Isco, USA). High‐resolution mass spectros-
copy (HR‐MS) spectra were obtained on a Waters Acquity
iClass UPLC coupled with Thermo Q Exactive Plus with
HESI source (Waters Co., USA), used in positive mode.
2.2.1 | 20‐Hydroxyecdysone 2,3‐acetonide
20‐O‐methyl‐oxime ether isomers 3
White solid; HR‐HESI‐MS: C25H38O5N, [M + H]
+ Calcd.
432.2750, found: 432.2749.
2.2.2 | Squalenoylated ecdysteroid conju-
gate 6
Colorless oil; HR‐HESI‐MS: C59H91O8NS2Na, [M + Na]
+
Calcd. 1028.60838, found: 1028.60949.
2.2.3 | Squalenoylated ecdysteroid conju-
gate 7
Colorless oil; HR‐HESI‐MS: C61H96O8N, [M + H]
+ Calcd.
970.70912, found: 970.71546.
2.3 | NMR spectroscopy
1H (950 or 500 MHz) and 13C (239 or 125 MHz) NMR
spectra were recorded at room temperature on Bruker
Avance III spectrometers equipped with cryo probeheads.
All of the NMR experiments on compound 6 were taken
at 950/239 MHz, the other compounds 2, 3, and 7 were
measured at 500/125 MHz. Amounts of approximately
1–5 mg of compounds 2, 3, 6, and 7 were dissolved in
0.6 ml of chloroform‐d and transferred to 5 mm NMR
sample tubes. Chemical shifts are given on the δ‐scale
and are referenced to the solvent chloroform‐d: δC = 77.00
and δH = 7.27 ppm. Pulse programs of all experiments
(1H, 13C, DEPTQ, 1D sel‐ROESY [τmix: 300 ms], 1D sel‐
TOCSY, gs‐HSQC, and gs‐HMBC [optimized for 8 and
10 Hz, respectively]), and band‐selective‐HMBC were
taken from the Bruker software library. For 1D measure-
ment, 64 K data points were used to yield the FID. Spec-
tral widths for the 500 MHz 1H spectra were set to
6,500 Hz, whereas in case of 950 MHz to 7,600 Hz. For
2D measurements, on the 500 MHz spectrometer in case
of the HSQC spectrum, the sweep width in F2 was
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7,000 Hz; data points (t2 × t1) were acquired with
2 K × 128, in case of the HMBC spectrum, the sweep
width in F2 was 4,000 Hz; data points (t2 × t1) were
acquired with 2 K × 256, respectively. In the band‐selec-
tive HMBC experiment applied for compound 7, the used
digital resolution was 1.95/1.71 Hz per point. For 2D
measurements, on the 950 MHz spectrometer in case of
the HSQC spectrum, the sweep width in F2 was
7,600 Hz; data points (t2 × t1) were acquired with
2 K × 4 K, in case of the HMBC spectrum, the sweep
width in F2 was 7,600 Hz; data points (t2 × t1) were
acquired with 16 K × 8 K, respectively. For F1, linear
prediction was applied to enhance the resolution. To
achieve an appropriate separation of signals, we uti-
lized 1.86/3.61 and 0.93/2.91 Hz per point digital reso-
lution for the HSQC and HMBC experiments,
respectively. Most 1H assignments were accomplished
using general knowledge of chemical shift dispersion
TABLE 1 1H and 13C chemical shifts, multiplicities, and characteristic coupling constants of the steroid part of compounds 2, 3, 6, and 7 in
chloroform‐d
Atom
no.
2 3 (3Z) 6 7
H C H C H J (Hz)a C H C
1β 1.26 37.58 1.25 37.59 1.27 m 37.61 1.26 37.58
α 1.98 1.97 1.98 m 1.97
2 4.25 72.10 4.25 72.10 4.25ddd 10.0;6.0;4.7 72.10 4.25 72.08
3 4.29 71.55 4.29 71.56 4.29ddd 4.7;4.7;2.3 71.55 4.29 71.54
4β 2.11 26.64 2.11 26.65 2.13 m 26.66 2.11 26.63
α 1.83 1.83 1.83ddd 15.3;12.5;4.7 1.83
5 2.37 50.81 2.37 50.83 2.38dd 12.5;4.7 50.82 2.37 50.81
6 ‐ 202.65 ‐ 202.72 ‐ 202.42 ‐ 202.55
7 5.85 121.49 5.84 121.37 5.86d 2.6 121.69 5.84 121.63
8 ‐ 162.15 ‐ 162.45 ‐ 161.73 ‐ 161.91
9 2.86 34.60 2.85 34.61 2.86ddd 11.7;7.0;2.6 34.60 2.86 34.54
10 ‐ 37.83 ‐ 37.84 ‐ 37.84 ‐ 37.83
11β 1.61 20.59 1.61 20.61 1.61 m 20.60 1.61 20.57
α 1.80 1.78 1.80 m 1.79
12β 1.66 29.85 1.66 29.89 1.70 m 29.90 1.69 29.87
α 2.17 2.14 2.19ddd 13.0;13.0;4.9 2.19
13 ‐ 48.05 ‐ 47.71 ‐ 48.08 ‐ 48.06
14 ‐ 84.38 ‐ 84.47 ‐ 84.39 ‐ 84.33
15β 2.10 32.04 2.08 32.00 2.13 m 32.08 2.08 32.01
α 1.60 1.57 1.61 m 1.57
16β 2.30 21.24 2.35 21.17 2.44 m 21.35 2.44 21.30
α 1.94 1.89 2.00 m 1.99
17 3.11 51.33 3.04 51.35 3.21dd 9.0;9.0 51.95 3.21 51.94
18 0.63 17.20 0.63 (0.69) 17.18 (18.26) 0.70 s 17.36 0.69 17.33
19 0.99 23.60 0.99 (0.86) 23.60 (23.60) 1.00 s 23.60 0.99 23.58
20 ‐ 158.53 ‐ 156.40 ‐ 166.08 ‐ 165.94
21 1.92 15.53 1.83 (1.92) 16.02 (20.26) 1.98 s 17.48 1.83 17.44
22 ‐ 108.32 ‐ 108.29 ‐ 108.33 ‐ 108.33
Meβ‐22 1.50 28.53 1.50 28.52 1.51 s 28.53 1.50 28.52
Meα‐22 1.34 26.44 1.34 26.44 1.35 s 26.44 1.34 26.43
MeO ‐ ‐ 3.85 (3.87) 61.32 (61.53) ‐ ‐ ‐ ‐
aBecause the stereostructure of the steroid frame is identical within compounds of this table, we described the J coupling constants only for 6 detected at
950 MHz. s = singlet, d = doublet, m = unresolved multiplet.
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with the aid of the proton–proton coupling pattern (1H
NMR spectra). The NMR signals of the products were
assigned by comprehensive one‐ and two‐dimensional
NMR methods using widely accepted strategies.[13,14]
The 1H and 13C NMR data for the steroid moiety of
compounds 2–3 and 6–7 are compiled in Table 1,
whereas the signals of the R‐groups in compounds 6
and 7 are summarized in Table 2. The characteristic
NMR and HRMS spectra of compounds 2–3 and 6–7
are presented as Supporting Information.
3 | RESULTS AND DISCUSSION
Savchenko and coworkers most recently reported the 1H
and 13C NMR data of 20‐oxime derivative of posterone
2,3‐acetonide (2), and on the basis of its X‐ray single crys-
tal investigation, they proved the (E)‐configuration of the
oxime moiety.[10] As in the 1H and 13C NMR spectra of
this compound only one set of signals appeared, the mea-
sured diamagnetic change of δC‐20 (Δδ 51 ppm) sup-
ported the C═O → C═NOH conversion, but in the
absence of exact data of Δδ syn‐anti parameters for the
C‐21 signal, the unambiguous identification of the E/Z
isomerism was not possible. We have also taken the
NMR spectra of compound 2 (see Figures S1–S5), and
the NMR data are included in Table 1.
Our HMBC measurement (see Figure S5, cross‐peaks
H‐9/C‐11 and H‐17/C‐16) revealed that the assignment of
the CH2 signals in positions 11 and 16 is in fact the oppo-
site as compared to that published.[10] Furthermore, based
on the edited‐HSQC spectrum (Figure S4), we achieved
full assignment of the diastereotopic methylene hydrogen
atoms as well. It should be mentioned that no remarkable
NOE sterical interaction could be observed between the
broad OH and the H3‐21 (1.92 s) hydrogen atoms, not even
when dmso‐d6 was used as solvent. To overcome this prob-
lem, we synthetized and investigated also the correspond-
ing ―OCH3 20‐oxime‐methylether derivate (3). Two sets
of signals were observed in the NMR spectra in ratio of
95/5, and for the major component, complete 1H and 13C
assignment was achieved. In order to differentiate the β
or α position of the hydrogen atoms, we utilized a series
of selective ROESY experiments (Figure S8). Irradiation
of the OCH3 signal resulted in steric response on the H3‐
21 signal (1.83 ppm), and thereby, we now have an
unequivocal proof of the E configuration of the oxime
group. Even though the signal at 1.83 ppm consists of
the overlapping H3‐21 and Hα‐4 signals, this experiment
marked out not only the OCH3 but also H‐2, H‐3, Hβ‐4,
H‐9, Hβ‐16, H‐17, and H3‐18. In addition to this, the exper-
iments on H3‐18 and H3‐19 resulted in the stereostructure
and complete 1H assignments (see Figure 2).
TABLE 2 1H and 13C chemical shifts of the R group in com-
pounds 6 and 7 in chloroform‐d
Atom
no.
6 7
H C H C
1′ ‐ 170.73 ‐ 171.43
2′ 2.59 31.19 2.43 33.0
3′ 2.11 23.96 1.68 24.81
4′ 2.78 37.62 1.41–1.27 29.08
5′ ‐ ‐ 29.08
6′ ‐ ‐ 29.08
7′ 2.73 37.78 29.08
8′ 2.03 24.22 1.61 24.94
9′ 2.44 32.62 2.29 34.32
10′ ‐ 172.95 ‐ 173.91
11′ ‐ ‐ ‐ ‐
12′ 4.05 64.27 4.04 63.99
13′ 1.73 26.86 1.72 26.86
14′ 2.03 35.78 2.03 35.77
15′ ‐ 133.61 ‐ 133.67
16′ 5.14 125.13 5.13 125.03
17′ 2.08 26.66 2.08 26.63
18′ 1.99 39.67 1.98 39.65
19′ ‐ 135.13 ‐ 135.11
20′ 5.15 124.38 5.14 124.35
21′ 2.02 28.26a 2.01 28.24
22′ 2.02 28.27a 2.01 28.24
23′ 5.155 124.27 5.14 124.25
24′ ‐ 134.97 ‐ 134.96
25′ 1.99 39.75 1.98 39.73
26′ 2.08 26.66 2.08 26.63
27′ 5.13 124.25 5.12 124.23
28′ ‐ 134.91 ‐ 134.89
29′ 1.98 39.72 1.98 39.71
30′ 2.07 26.76 2.06 26.74
31′ 5.11 124.40 5.10 124.37
32′ ‐ 131.26 ‐ 131.25
33′ 1.69 25.70 1.68 25.69
34′ 1.61 17.68 1.60 17.67
35′ 1.61 16.00 1.60 15.99
36′ 1.61 16.05 1.60 16.03
37′ 1.61 16.04 1.60 16.02
38′ 1.61 15.87 1.60 15.86
aTentative assignment.
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In the edited HSQC spectrum of compound 3 (Figure
S12), we have clearly identified the CH3‐18 (0.69/
18.26 ppm) and CH3‐21 (1.92/20.26 ppm) signals also for
the minor isomer.
It should be mentioned that in case of the oxime
derivative compound 2, the C‐21 signal appeared at
15.53 ppm nearly at the same chemical shift as in the
main component of compound 3 (16.02 ppm). This value
unequivocally proofs the E configuration of the oxime
group. That means that compound 2 appears in solution
in the same configuration as in solid phase.[10]
The detected Δδ = 4.2 ppm syn‐anti parameter on the
C‐21 signal in compound 3 is in good agreement with
our results on C‐6 oxime derivatives of ecdysteroids[4]
and unambiguously confirmed the NMR differentiation
of the E/Z isomers. Considering the detected δC‐21
(17 ppm) in compounds 6 and 7, we can conclude that
these compounds are also 20(E)‐oxime derivatives. The
appearance of five ═CH signals of the R‐groups in the 1H
(δ5.20–5.00 ppm) and 13C (δ 125.2–124.2 ppm) NMR spec-
tra of compounds 6 and 7 justifies the connection of the
long lipophilic side‐chain (OR). The atomic numbering
for the OR group is shown in Figure 3, and corresponding
NMR data are summarized in Table 2.
In the 1H spectrum of compound 6 (Figure S13), the
identification of the two O═C―CH2CH2CH2―S moieties
was achieved by sel‐TOCSY experiments (see Figure S14),
and irradiation on the H2‐12′ signal (δ4.05 ppm) led to
the assignment of the O═C―O―CH2CH2CH2―C═ moi-
ety (see Figure S14). Considering the H2‐12′/C‐10′ cross‐
peaks (4.05/172.95‐ppm) in the HMBC spectrum (Figure
S21), the differentiation between the C‐10′ and C′‐1 ester
carbon atoms is straightforward. The H2‐13′ and H2‐14′
hydrogens clearly give HMBC correlation to C‐15′
(δ133.61 ppm; Figure S23), and this way the complete
NMR assignment of C‐1′–C‐15′ fragment is revealed. In
addition to this, the third cross‐peak to C‐15′ in this spec-
trum marked out δH2‐17′ at 2.08 ppm. The H2‐14′/C‐16′
(2.03/125.13 ppm) HMBC response (see Figure S22)
assigned δC‐16′, while the cross‐peak at 1.99/125.13
revealed the δH2‐18′ chemical shift. At the same time,
the H2‐17′ and H2‐18′ hydrogens show HMBC correla-
tions to C‐19′, and this way the signal at δ135.13 can be
assigned to this carbon atom. While C‐19′ displays a fur-
ther HMBC cross‐peak to a methylene group, this signal
at δ2.02 ppm should be H2‐21. In the
1H spectrum, the
intensity of this signal is 4H, and in the edHSQC, we
detected two methylene signals at 28.26 and 28.27 ppm
(controlled also with volume integration); we concluded
that the latter should belong to the CH2 group in position
C‐22′. This way the H2‐22′/C‐24′ HMBC correlation
established the δC‐24′ = 134.97 ppm assignment. This
FIGURE 2 Stereostructure of compound 3 and one‐dimensional selective rotating frame Overhauser enhancement spectroscopy (ROESY)
responses. The red arrows indicate characteristic steric proximities detected by irradiation at MeO, H3‐21+ Hα‐4, H3‐18, and H3‐19 signals,
blue numbers refer to 1H chemical shifts, and black cursive numbers denote atomic numbering
FIGURE 3 Atomic numbering of the long lipophilic side‐chain. X = S (compound 6) or CH2 (compound 7)
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carbon atom shows long‐range correlation also with the
H2‐25′ (δ1.99 ppm) hydrogens.
To continue the signal assignment of the side chain R,
we examined the CH3 signals. Five methyl groups resonate
in the 1H NMR at 1.61 ppm, but the sixth CH3 appears sep-
arately as a quartet (J ~ 1 Hz) at 1.69 ppm, and in the
edited HSQC spectrum (Figures S17–S18), the correspond-
ing cross‐peak is at 1.69/25.70 ppm. In the HMBC experi-
ment (Figure S20), the 1.69/17.68 correlation identified a
geminal dimethyl group, that is, two that are situated on
the end of the side‐chain. Considering the well‐known γ‐
steric effect that necessarily takes place with the methy-
lene in position 31′, their assignment is δC‐34′ = 17.68
and δC‐33′ = 25.70 ppm. Utilizing a sel‐TOCSY experi-
ment irradiating at 1.69 ppm (Figure S15), we managed
to identify the H3‐34′, H‐31′, H2‐30′ and H2‐29′ signals
(because this irradiation affected also the Hβ‐12 atom of
the steroid frame, the Hα‐12, Hα‐11, H‐9 and H‐7 signals
also appeared). The remaining, so far not assigned quater-
nary sp2 = C signal at 134.91 ppm, can only be C‐28′,
which is strongly supported by the H2‐30′, H2‐29′ and H2‐
26′ (δ2.08) HMBC correlations (Figure S23).
In case of compound 7, we used the same methodol-
ogy as in case of 6, but the applied NMR frequency was
only 500/125 MHz. To achieve the appropriate resolution
also in the HSQC and HMBC measurements, we pre-
ferred here their band selective versions. The obtained
1H and 13C chemical shifts of 7 correlated perfectly with
the data of 6, with exception of the methylene groups of
the side chain between positions 2′ and 9′. The method
of choice for studying this structure fragment was again
the one‐dimensional sel‐TOCSY experiment (Figure S25).
Irradiation of the H2‐9′ signal at 2.29 ppm identified not
only the hydrogens till H2‐6′, but, through raising the
mixing time to 200 ms, we could reach till H2‐2′. Due to
the extremely similar 1H chemical shifts of the methy-
lenes in 4′–7′ positions, it was possible to enter for them
region 1.47–1.27 ppm. The experiment on H2‐12′ supplied
H2‐13′ and H2‐14′ data. Joint irradiation of the five ═CH
hydrogens in the 5.17–5.17 ppm area revealed all signals
of their spin systems.
In conclusion, we obtained for the first time the com-
plete 1H and 13C NMR signal assignment of ecdysteroid
C‐20‐oxime derivatives, including two new, promising
potential antitumor agent with a long lipophilic side‐
chain. The preparation of self‐assembling nanoparticles
from these latter two compounds, as well as their bioac-
tivity testing, will be reported in the near future.
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